Pierre Armand Morgon
Président chez EUROCINE VACCINES AB
Fortune : 25 519 $ au 30/04/2024
Profil
Dr. Pierre Armand Morgon is a Chairman at Kupando GmbH, a Non-Executive Chairman at Adiposs SA, a Chairman at MYCB1 BV, a Chairman at MYCB1 Group BV, an Independent Non-Executive Director at Barinthus Biotherapeutics Plc, a CEO and Founder at Mrgn Advisors, a Chairman at Eurocine Vaccines AB, a CEO at Drug Abuse Sciences, an Advisor at CUBE Labs Srl, a Chairman at Health Technology Holding Srl, a Chief Executive Officer & Manager at MRGN Advisors SARL and an Independent Non-Executive Director at Limula SA. He is on the Board of Directors at Amoéba SA, Univercells SA, Barinthus Biotherapeutics Plc and Limula SA. Dr. Morgon was previously employed as an Executive VP-Portfolio Strategy & Head-Europe by CanSino Biologics, Inc., a Non-Executive Director by Vaccitech Ltd., a Chairman by Alma Biotherapeutics, a Chairman by Virometix AG, a Chief Executive Officer by AJ Biologics Sdn.
Bhd., a Chairman by Theradiag SA, a VP-Franchise & Global Marketing Strategy by Sanofi Pasteur, a Chief Operating Officer by Onxeo SA, and a Marketing Director by Cegedim SA. He also served on the board at Schering-Plough SAS.
He received his undergraduate degree from INSEAD, an undergraduate degree from the International Institute for Management Development, a graduate degree from Jean Moulin University Law School, an MBA from ESSEC Business School and a doctorate degree from the University of Lyon.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/05/2024 | 10 506 ( 0,03% ) | 25 519 $ | 30/04/2024 |
Postes actifs de Pierre Armand Morgon
| Sociétés | Poste | Début |
|---|---|---|
| EUROCINE VACCINES AB | Président | 01/06/2019 |
| AMOÉBA | Directeur/Membre du Conseil | 17/12/2020 |
| BARINTHUS BIOTHERAPEUTICS PLC | Directeur/Membre du Conseil | 01/01/2018 |
| Drug Abuse Sciences | Directeur Général | 01/01/2006 |
Limula Biotech
 Limula Biotech Miscellaneous Commercial ServicesCommercial Services Limula Biotech operates as an automated gene therapy manufacturing platform. | Directeur/Membre du Conseil | - |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Consultant / Advisor | - |
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Président | 01/12/2021 |
| MYCB1 BV | Président | 01/07/2020 |
| MRGN Advisors SARL | Directeur Général | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Pierre Armand Morgon
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Pierre Armand Morgon
| INSEAD | Undergraduate Degree |
| International Institute for Management Development | Undergraduate Degree |
| ESSEC Business School | Masters Business Admin |
| University of Lyon | Doctorate Degree |
| Jean Moulin University Law School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| EUROCINE VACCINES AB | Health Technology |
| CEGEDIM | Technology Services |
| VALERIO THERAPEUTICS | Health Technology |
| AMOÉBA | Consumer Non-Durables |
| CANSINO BIOLOGICS INC. | Health Technology |
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Entreprise privées | 18 |
|---|---|
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Health Technology |
AJ Biologics Sdn. Bhd.
 AJ Biologics Sdn. Bhd. BiotechnologyHealth Technology AJ Biologics Sdn. Bhd develops and manufactures biological products. It specializes in vaccine formulations. The company is headquartered in Kuala Lumpur, Malaysia. | Health Technology |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Health Technology |
CUBE Labs Srl
CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Finance |
Virometix AG
 Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Health Technology |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | Commercial Services |
| Alma Biotherapeutics | |
| Mrgn Advisors | |
| Drug Abuse Sciences | |
Health Technology Holding Srl
 Health Technology Holding Srl Investment ManagersFinance Health Technology Holding Srl (HTC), is a venture capital subsidiary of Gefim SpA founded in 2019. The firm is headquartered in Milan, Italy. | Finance |
Kupando GmbH
Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Health Technology |
Limula Biotech
Limula Biotech Miscellaneous Commercial ServicesCommercial Services Limula Biotech operates as an automated gene therapy manufacturing platform. | Commercial Services |
Adiposs SA
 Adiposs SA Medical SpecialtiesHealth Technology Adiposs SA is a Swiss medical imaging company that has developed imagebat-enhanced CT scan technology. The company is based in Plan-les-Ouates, Switzerland. The technology is fast, pain-free, and can be made available in every hospital and organization worldwide that provides CT scans. The company's co-inventor, Andrej Babic, has co-authored more than 30 scientific papers and holds several patents in the fields of medical imaging, photodynamic therapy, and nanotechnology. The company's team includes experts in preclinical development, clinical trials, and drug development across multiple therapeutic areas. Adiposs was founded by Nathalie Stransky-Heilkron, Andrej Babic, and Justyna Plewka Ma. Andrej Babic has been the CEO since incorporation. | Health Technology |
| MYCB1 Group BV | |
| MRGN Advisors SARL | |
| MYCB1 BV |